
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+17
With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs. Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves: Next generation antibody-drug conjugates (ADCs), including...
Oncology,autoimmune,adcs,mabs,linker-drug technology,gmp manufacturing,biopharmaceuticals,immuno-oncology,breastcancer,cancer,biotechnology,biomarker development & discovery,cmc,usp,dsp,medicinal & protein chemistry,pharmacology,drug metabolism & pharmacokinetics,chemistry,manufacturing and controls,oncology,and manufacturing
Byondis operates in the Pharmaceutical manufacturing industry.
Byondis's revenue is 11m - 100m
Byondis has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.